Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28202611)
Watch
English
Oncolytic herpes simplex virus vectors for cancer virotherapy
scientific article (publication date: December 2002)
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Oncolytic herpes simplex virus vectors for cancer virotherapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
main subject
vector-borne disease
0 references
oncolytic virus
1 reference
based on heuristic
inferred from title
author
Samuel D Rabkin
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
author name string
Susan Varghese
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
language of work or name
English
0 references
publication date
1 December 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
published in
Cancer Gene Therapy
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
issue
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
page(s)
967-978
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
cites work
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Pathogenicity of Ribonucleotide Reductase-Null Mutants of Herpes Simplex Virus Type 1 in Mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys (Aotus trivirgatus)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor model.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prodrug-activating systems in suicide gene therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptional targeting of herpes simplex virus for cell-specific replication
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Replicative adenoviruses for cancer therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intralesional injection of herpes simplex virus 1716 in metastatic melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The current status of clinical gene therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of preexisting anti-herpes immunity on the efficacy of herpes simplex viral therapy in a murine intraperitoneal tumor model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting gene expression using HSV vectors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting adenovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reovirus therapy of tumors with activated Ras pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FSJ.CGT.7700537
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/SJ.CGT.7700537
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2561859
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
Fatcat ID
release_qiej2s6ewjhnpn6zrnaiw6cqdy
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/qiej2s6ewjhnpn6zrnaiw6cqdy
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
OpenCitations bibliographic resource ID
2561859
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2561859
PubMed publication ID
12522436
2 references
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
2561859
stated in
Europe PubMed Central
PubMed publication ID
12522436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12522436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
16 December 2019
ResearchGate publication ID
10956356
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
